These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7759393)

  • 1. Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams.
    Ciofu O; Giwercman B; Walter-Rasmussen J; Pressler T; Pedersen SS; Høiby N
    J Antimicrob Chemother; 1995 Feb; 35(2):295-304. PubMed ID: 7759393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
    Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N
    Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against chromosomal beta-lactamase.
    Giwercman B; Rasmussen JW; Cioufu O; Clemmentsen I; Schumacher H; Høiby N
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2306-10. PubMed ID: 7840561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.
    Ciofu O; Pressler T; Pandey JP; Høiby N
    Clin Exp Immunol; 1997 Apr; 108(1):88-94. PubMed ID: 9097916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.
    Ciofu O; Bagge N; Høiby N
    APMIS; 2002 Dec; 110(12):881-91. PubMed ID: 12645667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
    Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C
    Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
    Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment.
    Giwercman B; Meyer C; Lambert PA; Reinert C; Høiby N
    Antimicrob Agents Chemother; 1992 Jan; 36(1):71-6. PubMed ID: 1590704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Fomsgaard A; Høiby N; Shand GH; Conrad RS; Galanos C
    Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.
    Giwercman B; Lambert PA; Rosdahl VT; Shand GH; Høiby N
    J Antimicrob Chemother; 1990 Aug; 26(2):247-59. PubMed ID: 2170321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis.
    Ciofu O; Petersen TD; Jensen P; Høiby N
    Thorax; 1999 Feb; 54(2):141-4. PubMed ID: 10325919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
    J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa.
    Ciofu O; Beveridge TJ; Kadurugamuwa J; Walther-Rasmussen J; Høiby N
    J Antimicrob Chemother; 2000 Jan; 45(1):9-13. PubMed ID: 10629007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
    Ciofu O; Giwercman B; Pedersen SS; Høiby N
    APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.